Hypoxic Conditioned Medium from Human Amniotic Fluid-derived Mesenchymal Stem Cells Accelerates Skin Wound Healing Through TGF-β/SMAD2 and PI3K/Akt Pathways
Overview
Chemistry
Molecular Biology
Authors
Affiliations
In a previous study, we isolated human amniotic fluid (AF)-derived mesenchymal stem cells (AF-MSCs) and utilized normoxic conditioned medium (AF-MSC-norCM) which has been shown to accelerate cutaneous wound healing. Because hypoxia enhances the wound healing function of mesenchymal stem cell-conditioned medium (MSC-CM), it is interesting to explore the mechanism responsible for the enhancement of wound healing function. In this work, hypoxia not only increased the proliferation of AF-MSCs but also maintained their constitutive characteristics (surface marker expression and differentiation potentials). Notably, more paracrine factors, VEGF and TGF-β1, were secreted into hypoxic conditioned medium from AF-MSCs (AF-MSC-hypoCM) compared to AF-MSC-norCM. Moreover, AF-MSC-hypoCM enhanced the proliferation and migration of human dermal fibroblasts in vitro, and wound closure in a skin injury model, as compared to AF-MSC-norCM. However, the enhancement of migration of fibroblasts accelerated by AF-MSC-hypoCM was inhibited by SB505124 and LY294002, inhibitors of TGF-β/SMAD2 and PI3K/AKT, suggesting that AF-MSC-hypoCM-enhanced wound healing is mediated by the activation of TGF-β/SMAD2 and PI3K/AKT. Therefore, AF-MSC-hypoCM enhances wound healing through the increase of hypoxia-induced paracrine factors via activation of TGF-β/SMAD2 and PI3K/AKT pathways.
Sandra F, Dewi D, Astawa I, Pangkahila W, Chouw A, Celinna M Iran J Med Sci. 2025; 50(1):44-53.
PMID: 39957810 PMC: 11829070. DOI: 10.30476/ijms.2024.100856.3342.
Rhein promotes skin wound healing by activating the PI3K/AKT signaling pathway.
Yang D, Li W, Xiang P, Ge T, Li H, Zhang Y Open Med (Wars). 2024; 19(1):20241116.
PMID: 39726811 PMC: 11669899. DOI: 10.1515/med-2024-1116.
Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes.
Wu S, Zhou Z, Li Y, Jiang J Heliyon. 2024; 10(17):e37031.
PMID: 39286219 PMC: 11403009. DOI: 10.1016/j.heliyon.2024.e37031.
The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?.
Younesi F, Hinz B Int J Mol Sci. 2024; 25(16).
PMID: 39201399 PMC: 11354465. DOI: 10.3390/ijms25168712.
Xu L, Yu X, Zhang N, Chen Y World J Stem Cells. 2024; 16(6):708-727.
PMID: 38948096 PMC: 11212552. DOI: 10.4252/wjsc.v16.i6.708.